DEVELOPING POTENT URATE TRANSPORTER INHIBITORS: COMPOUNDS DESIGNED FOR THEIR URICOSURIC ACTION
申请人:Wempe Michael F.
公开号:US20130225673A1
公开(公告)日:2013-08-29
A compound represented by the general Formula I:
a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a pro-drug thereof, a deuterated radio-labeled analog thereof, and mixtures of any of the foregoing, wherein: A-K are individually selected from carbon or nitrogen;
X═—O, —NR
1
, or —S; R
1-11
are individually selected from the group consisting of —H, C
1
-C
6
alkyl, C
6
-C
14
aryl, substituted C
6
-C
14
aryl, C
1
-C
14
-alkoxy, halogen, hydroxyl, carboxy, cyano, C
1
-C
6
-alkanoyloxy, C
1
-C
6
-alkylthio, C
1
-C
6
-alkylsulfonyl, trifluoromethyl, hydroxy, C
2
-C
6
-alkoxycarbonyl, C
2
-C
6
-alkanoylamino, —O—R
12
, S—R
12
, —SO
2
—R
12
, —NHSO
2
R
12
and —NHCO
2
R
12
, wherein R
12
is phenyl, naphthyl, or phenyl or naphthly substituted with one to three groups selected from C
1
-C
6
-alkyl, C
6
-C
10
aryl, C
1
-C
6
-alkoxy and halogen, and C
4
-C
20
hydroxyheteroaryl wherein the heteroatoms are selected from the group consisting of sulfur, nitrogen, and oxygen.
一种由通式I表示的化合物:其中,该化合物为药学上可接受的盐或酯、溶剂化物、螯合物、非共价复合物、前药、氘标记的放射性类似物或任何上述物质的混合物,其中:A-K分别选择自碳或氮;X═—O、—NR1或—S;R1-11分别选择自—H、C1-C6烷基、C6-C14芳基、取代的C6-C14芳基、C1-C14烷氧基、卤素、羟基、羧基、氰基、C1-C6-烷酰氧基、C1-C6-烷基硫基、C1-C6-烷基磺酰基、三氟甲基、羟基、C2-C6-烷氧羰基、C2-C6-烷酰胺基、—O—R12、S—R12、—SO2—R12、—NHSO2R12和—NHCO2R12,其中R12为苯基、萘基或苯基或萘基,且其上选择了一到三个来自C1-C6烷基、C6-C10芳基、C1-C6烷氧基和卤素的基团以及C4-C20羟基杂芳基,其中杂原子选择自硫、氮和氧。